Circle Pharma

Circle Pharma operates an indication-agnostic discovery engine for the development of cell permeable macro-cyclic peptide therapeutics. We deploy our computational structure-based design approach against important therapeutic targets that are challenging to address with conventional small molecules. The company was founded in 2012 and is headquartered in San Francisco, California.